Cognis (defibrillator)

2019: Announcement

At the beginning of November, 2019 it became known that Boston Scientific hid from regulators defects in defibrillators. In the resolution of October 16 the judge Steven Rau accused Boston Scientific of fraud as the company did not announce the Food and Drug Administration (FDA) expected defects of a defibrillator of Cognis and the implanted Teligen kardiovertera-defibrillator.

Besides, the judge pointed the companies that she intentionally created obstacles to trial on this case, hiding material witnesses.

it became known that Boston Scientific hid from regulators defects in defibrillators.

Boston Scientific learned about defects of defibrillators after the output of devices to the European market. However when the company released the reviewed versions of devices in the USA, it called new models the modified, but not corrected versions. Boston Scientific recalled original devices in the middle of 2009.

Besides, during judicial proceedings it was opened that provided to Boston Scientific not all employee names which could be responsible for fraud. In the resolution of October 16 Rau accused the company of intended information hiding from court, suspecting that the company wished to expose the new witness at the end of trial. The judge Rau ordered that Boston Scientific should provide names of all employees who are potentially involved in the fraudulent scheme within 14 days after pronouncement of the resolution.

Boston Scientific gave objection against Rau's resolution, having stated that it did not conceal intentionally names of witnesses. The company notes that the new witness was dobavlen at the end of trial because of the inconvenient diagram of evidence. Boston Scientific called charges of the judge Rau "supported with nothing, speculative and contradicting materials which were provided to court".^[1]

Notes